HomeCompareGUOSF vs MRK

GUOSF vs MRK: Dividend Comparison 2026

GUOSF yields 3.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GUOSF wins by $414.32M in total portfolio value
10 years
GUOSF
GUOSF
● Live price
3.00%
Share price
$2.00
Annual div
$0.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$414.38M
Annual income
$389,434,269.58
Full GUOSF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GUOSF vs MRK

📍 GUOSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGUOSFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GUOSF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GUOSF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GUOSF
Annual income on $10K today (after 15% tax)
$254.90/yr
After 10yr DRIP, annual income (after tax)
$331,019,129.14/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GUOSF beats the other by $331,010,800.73/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GUOSF + MRK for your $10,000?

GUOSF: 50%MRK: 50%
100% MRK50/50100% GUOSF
Portfolio after 10yr
$207.22M
Annual income
$194,722,033.86/yr
Blended yield
93.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GUOSF
No analyst data
Altman Z
0.5
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GUOSF buys
0
MRK buys
0
No recent congressional trades found for GUOSF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGUOSFMRK
Forward yield3.00%2.76%
Annual dividend / share$0.06$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$414.38M$56.8K
Annual income after 10y$389,434,269.58$9,798.13
Total dividends collected$412.53M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GUOSF vs MRK ($10,000, DRIP)

YearGUOSF PortfolioGUOSF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,300$599.77$11,206$366.19+$94.00GUOSF
2$13,358$1,266.77$12,650$502.35+$708.00GUOSF
3$17,092$2,798.98$14,407$694.19+$2.7KGUOSF
4$24,982$6,694.24$16,585$967.82+$8.4KGUOSF
5$45,020$18,289.28$19,342$1,363.89+$25.7KGUOSF
6$109,777$61,605.57$22,913$1,947.19+$86.9KGUOSF
7$398,245$280,783.07$27,662$2,823.89+$370.6KGUOSF
8$2,330,070$1,903,947.78$34,159$4,173.35+$2.30MGUOSF
9$23,315,066$20,821,891.69$43,337$6,308.80+$23.27MGUOSF
10$414,381,390$389,434,269.58$56,776$9,798.13+$414.32MGUOSF

GUOSF vs MRK: Complete Analysis 2026

GUOSFStock

Guotai Junan Securities Co., Ltd. provides various financial services for individuals and institutional clients in Mainland China, Hong Kong, and internationally. It operates through Wealth Management Business, Investment Banking Business, Institutional and Trading Business, Investment Management Business, and International Business segments. The company offers securities and futures brokerage, financial products, investment advisory, margin financing and securities lending, securities repurchase, and stock pledging and other services; listing sponsorship, equity underwriting, debt underwriting, structured debt financing, M&A financial advisory, and diversified corporate solutions to corporate and governmental clients; institutional brokerage, trading, investment and equity investment, seat leasing, custody and outsourcing, QFII, and other services; and investment transactions in stocks, fixed income, foreign exchange, and commodities and their derivative financial instruments, as well as integrated financial solutions for clients' investment, financing, and risk management. It also provides asset management and fund management services; and brokerage, corporate finance, asset management, and loans and financing services, as well as financial products, and market making and investment services. In addition, the company offers real estate and property management, warehouse service, corporate management consulting, venture capital investment and management, investment management, industrial investment, and investment consulting services. The company was founded in 1992 and is based in Shanghai, China.

Full GUOSF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GUOSF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GUOSF vs SCHDGUOSF vs JEPIGUOSF vs OGUOSF vs KOGUOSF vs MAINGUOSF vs JNJGUOSF vs ABBVGUOSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.